| 1501 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
43 |
| 1502 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
74 |
| 1503 |
Apheresis |
Allogeneic |
T-cell Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
51 |
| 1504 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
59 |
| 1505 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
66 |
| 1506 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
68 |
| 1507 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
33 |
| 1508 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
48 |
| 1509 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Netherlands |
66 |
| 1510 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
USA |
57 |
| 1511 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Belgium |
56 |
| 1512 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
55 |
| 1513 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
24 |
| 1514 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
61 |
| 1515 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
71 |
| 1516 |
Apheresis |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Canada |
53 |
| 1517 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2025 |
Standard Therapy |
Germany |
62 |
| 1518 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2025 |
Standard Therapy |
Germany |
45 |
| 1519 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2025 |
Standard Therapy |
Germany |
61 |
| 1520 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2025 |
Standard Therapy |
Germany |
32 |
| 1521 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2025 |
Standard Therapy |
Germany |
62 |
| 1522 |
Apheresis |
Autologous |
Central Nervous System Lymphoma |
Hematology |
2025 |
Standard Therapy |
Germany |
75 |
| 1523 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2025 |
Standard Therapy |
Germany |
70 |
| 1524 |
Cord Tissue |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
6 |
| 1525 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
6 |
| 1526 |
Cord Tissue |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
4 |
| 1527 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
6 |
| 1528 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and Traumatic Cartilage |
Orthopedics |
2024 |
Experimental Therapy |
Poland |
50,3 |
| 1529 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and Traumatic Cartilage |
Orthopedics |
2024 |
Experimental Therapy |
Poland |
49,5 |
| 1530 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and Traumatic Cartilage |
Orthopedics |
2024 |
Experimental Therapy |
Poland |
58,11 |
| 1531 |
Cord Tissue |
Allogeneic – Unrelated |
Graft Versus Host Disease |
Hematology |
2024 |
Experimental Therapy |
Poland |
7,7 |
| 1532 |
Cord Tissue |
Allogeneic – Unrelated |
Graft Versus Host Disease |
Hematology |
2024 |
Experimental Therapy |
Poland |
15,7 |
| 1533 |
Cord Tissue |
Allogeneic – Unrelated |
Ovarian Dysfunction |
Gynecology |
2024 |
Experimental Therapy |
Poland |
48,1 |
| 1534 |
Cord Tissue |
Allogeneic – Related |
Severe Pulmonary Hypertension +Mitral Regurgitation |
Cardiovascular/Pulmonary |
2024 |
Experimental Therapy |
Romania |
2,6 |
| 1535 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic lateral sclerosis |
Neurology |
2024 |
Experimental Therapy |
Poland |
57,6 |
| 1536 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2024 |
Experimental Therapy |
Poland |
68,2 |
| 1537 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
17 |
| 1538 |
Cord Tissue |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
7 |
| 1539 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2024 |
Experimental Therapy |
Poland |
61,9 |
| 1540 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2024 |
Experimental Therapy |
Poland |
45,4 |
| 1541 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic lateral sclerosis |
Neurology |
2024 |
Experimental Therapy |
Poland |
56,9 |
| 1542 |
Cord Tissue |
Allogeneic – Unrelated |
Graft-versus-host disease |
Hematology |
2024 |
Experimental Therapy |
Poland |
0,10 |
| 1543 |
Cord Tissue |
Allogeneic – Unrelated |
Amyotrophic lateral sclerosis |
Neurology |
2024 |
Experimental Therapy |
Poland |
39,0 |
| 1544 |
Cord Tissue |
Allogeneic – Unrelated |
GvHD |
Neurology |
2024 |
Experimental Therapy |
Poland |
9,2 |
| 1545 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
5,11 |
| 1546 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
13,10 |
| 1547 |
Cord Tissue |
Allogeneic – Unrelated |
Leukodystrophy |
Neurology |
2024 |
Experimental Therapy |
Poland |
1,9 |
| 1548 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
7,11 |
| 1549 |
Cord Tissue |
Allogeneic – Unrelated |
Leukodystrophy |
Neurology |
2024 |
Experimental Therapy |
Poland |
1 |
| 1550 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebellar-spinal ataxia |
Neurology |
2024 |
Experimental Therapy |
Poland |
35,5 |
| 1551 |
Cord Tissue |
Allogeneic – Unrelated |
Leukodystrophy |
Neurology |
2024 |
Experimental Therapy |
Poland |
1,9 |
| 1552 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
4,5 |
| 1553 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
11 |
| 1554 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
10 |
| 1555 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
6 |
| 1556 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
4 |
| 1557 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Romania |
5 |
| 1558 |
Cord Blood |
Allogeneic |
Cerebral Palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
3,5 |
| 1559 |
Cord Blood |
Allogeneic |
Cerebral Palsy |
Neurology |
2024 |
Experimental Therapy |
Poland |
7,7 |
| 1560 |
Cord Blood |
Autologous |
CP |
Neurology |
2024 |
Experimental Therapy |
Hungary |
4 |
| 1561 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
3,7 |
| 1562 |
Cord Blood |
Autologous |
Pervasive Developmental Disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
5,9 |
| 1563 |
Cord Blood |
Autologous |
Pervasive developmental disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
4,8 |
| 1564 |
Cord Blood |
Allogeneic – Related |
fanconi aplastic anemia |
Hematology |
2024 |
Standard Therapy |
Turkey |
12 |
| 1565 |
Cord Blood |
Autologous |
Neuroblastoma |
Neurology |
2024 |
Standard Therapy |
Poland |
4 |
| 1566 |
Cord Blood |
Autologous |
Pervasive developmental disorder |
Neurology |
2024 |
Experimental Therapy |
Poland |
9,9 |
| 1567 |
Cord Blood |
Autologous |
Autism |
Neurology |
2024 |
Experimental Therapy |
Slovakia |
4 |
| 1568 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1569 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1570 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
75 |
| 1571 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
56 |
| 1572 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
23 |
| 1573 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
54 |
| 1574 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1575 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1576 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
65 |
| 1577 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
48 |
| 1578 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
72 |
| 1579 |
Bone Marrow Family |
Allogeneic |
Chronic Lymphocytic Leukemia Richter Transformation |
Hematology |
2024 |
Standard Therapy |
Poland |
55 |
| 1580 |
Bone Marrow Family |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
63 |
| 1581 |
Bone Marrow Family |
Allogeneic |
Follicular Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
48 |
| 1582 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
65 |
| 1583 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Germany |
58 |
| 1584 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1585 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome – Refractory Cytopenia Of Childhood |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1586 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome/ Myeloproliferative Neoplasms |
Hematology |
2024 |
Standard Therapy |
Germany |
61 |
| 1587 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome-MPN |
Hematology |
2024 |
Standard Therapy |
Poland |
71 |
| 1588 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Poland |
68 |
| 1589 |
Bone Marrow Family |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
64 |
| 1590 |
Bone Marrow Family |
Allogeneic |
Polycythemia Vera/Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Poland |
74 |
| 1591 |
Bone Marrow Family |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Germany |
62 |
| 1592 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
68 |
| 1593 |
Bone Marrow Family |
Allogeneic |
Myelodysplasia |
Hematology |
2024 |
Standard Therapy |
United Kingdom |
57 |
| 1594 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
69 |
| 1595 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
58 |
| 1596 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
60 |
| 1597 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
71 |
| 1598 |
Bone Marrow Family |
Allogeneic |
High risk Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Germany |
69 |
| 1599 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
74 |
| 1600 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
15 |